Literature DB >> 15297939

Pathology of upper gastrointestinal malignancies.

Mario Sarbia1, Karl Friedrich Becker, Heinz Höfler.   

Abstract

This review describes the most important macroscopic, histological, and molecular biological features of carcinomas of the esophagus, the gastroesophageal junction (GEJ), and the stomach. The three most frequent histological subtypes of upper GI tract carcinoma, ie, adenocarcinoma, squamous cell carcinoma, and small cell carcinoma, are considered. Important histological classifications of upper GI tract adenocarcinomas such as Lauren's classification and the World Health Organization (WHO) classification, as well as rare histological variants of esophageal and gastric cancer, are described. Routes of tumor spread and principles of tumor classification are outlined. Furthermore, descriptions of the immediate precursor lesions of upper GI tract carcinomas, ie, dysplasias, are included. Finally, somatic genetic and epigenetic changes, which are associated with tumor development in the upper GI tract, are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15297939     DOI: 10.1053/j.seminoncol.2004.04.020

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  17 in total

Review 1.  [Clinical aspects of premalignant lesions of the upper gastrointestinal tract].

Authors:  H-J Meyer
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

2.  Esophageal squamous cell carcinoma with entirely intramural growth pattern.

Authors:  Burkhard H A von Rahden; Björn L D M Brücher; Mario Sarbia
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

3.  Chondrosarcomatous differentiation in diffuse-type gastric carcinoma.

Authors:  Vincenzo Villanacci; Marco Gambarotti; Alessandro Ubiali; Giancarlo Cervi; Giuseppe Pulcini; Vittorio De Cesare; Gabrio Bassotti
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

4.  Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract.

Authors:  Erika Rosivatz; Karl-Friedrich Becker; Elisabeth Kremmer; Christina Schott; Kareen Blechschmidt; Heinz Höfler; Mario Sarbia
Journal:  Virchows Arch       Date:  2005-11-17       Impact factor: 4.064

5.  Expression profiling of gastric cancer samples by oligonucleotide microarray analysis reveals low degree of intra-tumor variability.

Authors:  Karolin Trautmann; Christine Steudel; Dana Grossmann; Daniela Aust; Gerhard Ehninger; Stephan Miehlke; Christian Thiede
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

6.  Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?

Authors:  Matthias Haas; Maike Büttner; Tilman T Rau; Rainer Fietkau; Gerhard G Grabenbauer; Luitpold V Distel
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

7.  Identification of signature genes for detecting hedgehog pathway activation in esophageal cancer.

Authors:  Ling Yang; Yuehong Bian; Shuhong Huang; Xiaoli Ma; Chi Zhang; Xiulan Su; Zi-Jiang Chen; Jingwu Xie; Hongwei Zhang
Journal:  Pathol Oncol Res       Date:  2011-01-06       Impact factor: 3.201

8.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

9.  Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour.

Authors:  Frédéric Bibeau; Marie-Christine Chateau; Michel Guiu; Eric Assenat; David Azria; Rosy Lavaill; Marc Ychou; Florence Boissière-Michot
Journal:  Virchows Arch       Date:  2007-11-16       Impact factor: 4.064

Review 10.  Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value.

Authors:  Felix Berlth; Elfriede Bollschweiler; Uta Drebber; Arnulf H Hoelscher; Stefan Moenig
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.